Effect of cyproterone acetate on alpha1-adrenoceptor subtypes in rat vas deferens

Brazilian Journal of Medical and Biological Research

Volumn 36, Issue 11, 2003, Pages 1571-1581

  Campos, M ^a   Morais, P L ^a   Pupo, A S ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Alpha1 adrenoceptors; Cyproterone acetate; Vas deferens

Indexed keywords

5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALKYLATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANDROGEN; BENOXATHIAN; CHLOROETHYLCLONIDINE; CYPROTERONE ACETATE; INDORAMIN; NORADRENALIN; PHENTOLAMINE; PRAZOSIN; RECEPTOR SUBTYPE; WB 4104; YOHIMBINE;

ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; MUSCLE CONTRACTION; NONHUMAN; PLASTICITY; RAT; STATISTICAL ANALYSIS; VAS DEFERENS;

EID: 0242659268     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2003001100015     Document Type: Article

References (25)

1. Zhong H & Minneman KP (1999). Alpha1-adrenoceptor subtypes. European Journal of Pharmacology, 375: 261-276.
2. Docherty JR (1998). Subtypes of functional alpha1- and alpha2-adrenoceptors. European Journal of Pharmacology, 361: 1-15.
3. Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD & Clarke DE (1997). Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. British Journal of Pharmacology, 121: 1127-1135.
4. Daniels DV, Gever JR, Jasper JR et al. (1999). Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies. European Journal of Pharmacology, 370: 337-343.
5. Garcia-Sainz JA, Vazquez-Prado J & del Carmen Medina L (2000). Alpha 1-adrenoceptors: function and phosphorylation. European Journal of Pharmacology, 389: 1-12.
6. Petitti N, Karkanias GB & Etgen AM (1992). Estradiol selectively regulates alpha 1B-noradrenergic receptors in the hypothalamus and preoptic area. Journal of Neuroscience, 12: 3869-3876.
7. Karkanias GB, Ansonoff MA & Etgen AM (1996). Estradiol regulation of alpha 1b-adrenoceptor mRNA in female rat hypothalamuspreoptic area. Journal of Neuroendocrinology 8: 449-455.
8. Pupo AS (1998). Functional effects of castration on alpha1-adrenoceptors in rat vas deferens. European Journal of Pharmacology, 351: 217-223.
9. Homma Y, Hamada K, Nakayama Y, Tsujimoto G & Kawabe K (2000). Effects of castration on contraction and alpha(1)-adrenoceptor expression in rat prostate. British Journal of Pharmacology, 131: 1454-1460.
10. Queiroz DB, Mendes FR, Porto CS & Avellar MC (2002). Alpha1-adrenoceptor subtypes in rat epididymis and the effects of sexual maturation. Biology of Reproduction, 66: 508-515.
11. Quesada A & Etgen AM (2002). Functional interactions between estrogen and insulin-like growth factor-I in the regulation of alpha 1B-adrenoceptors and female reproductive function. Journal of Neuroscience, 22: 2401-2408.
12. Campos M, Morais PL & Pupo AS (2003). Effects of castration and of testosterone replacement on alpha 1-adrenoceptor subtypes in the rat vas deferens. European Journal of Pharmacology, 471: 149-155.
13. Arunlakshana O & Schild HO (1959). Some quantitative uses of drug antagonists. British Journal of Pharmacology, 14: 48-58.
14. Lafayette SSL (1997). Papel modulador da inervagção autonômica e do hormônio sexual masculino sobre os canais de cálcio voltagem-dependentes e sua importância no processo contrátil em ducto deferente de rato. Doctoral thesis, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
15. Castillo CJ, Lafayette S, Caricati-Neto A, Sette M, Jurkiewicz NH, Garcia AG & Jurkiewicz A (1992). Low dihydropyridine receptor density in vasa deferentia of castrated rats. British Journal of Pharmacology, 105: 257-258.
16. Aboud R, Shafii M & Docherty JR (1993). Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. British Journal of Pharmacology, 109: 60-67.
17. Pupo AS, Jurkiewicz NH & Jurkiewicz A (1997). Functional change of the balance between alpha 1A and alpha 1B adrenoceptor populations after transplantation of the vas deferens to the intestine. Annals of the New York Academy of Sciences, 812: 193-195.
18. Burt RP, Chapple CR & Marshall I (1995). Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen. British Journal of Pharmacology, 115: 467-475.
19. Pupo AS, Cavenaghi DL, Campos M, Lucena Morais P, Jurkiewicz NH & Jurkiewicz A (1999). Effects of indoramin in rat vas deferens and aorta: concomitant alpha 1-adrenoceptor and neuronal uptake blockade. British Journal of Pharmacology, 127: 1832-1836.
20. Hanft G & Gross G (1989). Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. British Journal of Pharmacology, 97: 691-700.
21. Salles J & Badia A (1991). Mechanisms underlying the differential sensitivity to alpha 1-adrenoceptor activation in the bisected rat vas deferens. British Journal of Pharmacology, 102: 439-445.
22. 3H]prazosin binding to assess altered responsiveness of alpha 1-adrenoceptors in the vas deferens of spontaneously hypertensive rat. Naunyn-Schmiedeberg's Archives of Pharmacology, 356: 383-391.
23. Forray C, Bard JA, Wetzel JM et al. (1994). The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype. Molecular Pharmacology, 45: 703-708.
24. Laz TM, Forray C, Smith KE, Bard JA, Vaysse PJ, Branchek TA & Weinshank RL (1964). The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype. Molecular Pharmacology, 46: 414-422.
25. Scofield MA, Liu F, Abel PW & Jeffries WB (1995). Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. Journal of Pharmacology and Experimental Therapeutics, 275: 1035-1042.